Reversible infliximab-related lymphoproliferative disorder associated with Epstein-Barr virus in a patient with rheumatoid arthritis
โ Scribed by Atsushi Komatsuda; Hideki Wakui; Takashi Nimura; Ken-ichi Sawada
- Publisher
- Springer
- Year
- 2008
- Tongue
- English
- Weight
- 267 KB
- Volume
- 18
- Category
- Article
- ISSN
- 1439-7595
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Objective. A causative role for Epstein-Barr virus (EBV) in the development of lymphoma in patients with rheumatoid arthritis (RA) has been proposed. We investigated the molecular features of EBV-positive diffuse large cell lymphomas in 2 patients with RA. Methods. Southern blot analysis for immuno
Background. Recently, reports of Epstein-Barr virus (EBV)-induced lymphoproliferative disorders (LPD) have increased in number among immunosuppressed recipients of organ transplants. The importance of analyzing both the immunoglobulin gene and EBV termini is advocated for the investigation of pathog
## Abstract Lymphoproliferative disorder (LPD) is described in only a few children receiving chemotherapy for cancer. In all of them, an association between LPD and EBV (EpsteinโBarr Virus) was found. We report on a patient who developed LPD not associated with EBV while receiving chemotherapy for